Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
CardiologyAnalysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
CardiologyEffect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
CardiologyKidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
CardiologyMode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
NYHA FC and Finerenone Response: Clinical Trial Insights
CardiologyNYHA FC and Finerenone Response: Clinical Trial Insights
- 5 questions
Novel Transcatheter Solution Approved for Tricuspid Regurgitation
Medical Industry FeatureNovel Transcatheter Solution Approved for Tricuspid Regurgitation
Advancing Cardiology and Heart Surgery Through a History of Collaboration
Medical Industry FeatureAdvancing Cardiology and Heart Surgery Through a History of Collaboration
Aiming Lower: Addressing the Gaps in LDL-C Management for ASCVD Patients
Medical Industry FeatureAiming Lower: Addressing the Gaps in LDL-C Management for ASCVD Patients
CV Risk in Patients with Narcolepsy: See the Data
Medical Industry FeatureCV Risk in Patients with Narcolepsy: See the Data
From Symptoms to Diagnosis: Navigating ATTR Amyloidosis in Clinical Practice
Medical Industry FeatureFrom Symptoms to Diagnosis: Navigating ATTR Amyloidosis in Clinical Practice
Uncovering Unmet Needs in ATTR Amyloidosis
Medical Industry FeatureUncovering Unmet Needs in ATTR Amyloidosis
- 04/02/2025
- medicalxpress.com04/01/2025
- 04/01/2025
- medicalxpress.com04/01/2025
- medicalxpress.com04/01/2025
- 04/01/2025
medicalxpress.com